Crossmark

Efficacy and Pharmacodynamic Target Attainment for Ceftazidime–Avibactam Off-Label Dose Regimens in Patients with Continuous or Intermittent Venovenous Hemodialysis: Two Case Reports

Crossref DOI link: https://doi.org/10.1007/s40121-022-00621-z

Published Online: 2022-04-08

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Xiao-Shan

Wang, Yu-Zhen

Shi, Da-Wei

Xu, Fang-Min

Yu, Jun-Hui

Chen, Jie

Lin, Guan-Yang

Zhang, Chun-Hong

Yu, Xu-Ben http://orcid.org/0000-0003-1897-4519
Tang, Cong-Rong
License Information

Text and Data Mining valid from 2022-04-08

Version of Record valid from 2022-04-08
More Information

Article History

Received: 7 January 2022

Accepted: 4 March 2022

First Online: 8 April 2022

Change Date: 5 November 2022

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s40121-022-00675-z

Updates are available Correction dated 2022-11-05

Click to view Correction: https://doi.org/10.1007/s40121-022-00675-z